QSAR: Hydropathic analysis of inhibitors of the p53-mdm2 interaction

Proteins: Structure, Function and Genetics

Volumn 45, Issue 3, 2001, Pages 169-175

  Galatin, Peter S ^a   Abraham, Donald J ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Drug design; HINT; Hydropathic; Molecular modeling; QSAR

Indexed keywords

PROTEIN MDM2; PROTEIN P53;

ARTICLE; COVALENT BOND; CRYSTAL STRUCTURE; CRYSTALLOGRAPHY; HYDROPHOBICITY; MOLECULAR DYNAMICS; MOLECULAR MODEL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; QUANTITATIVE STRUCTURE ACTIVITY RELATION; VALIDATION PROCESS;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMALS; CRYSTALLOGRAPHY, X-RAY; HUMANS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MUTAGENESIS; NEOPLASM PROTEINS; NUCLEAR PROTEINS; PEPTIDE FRAGMENTS; PEPTIDE LIBRARY; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MDM2; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; TUMOR SUPPRESSOR PROTEIN P53; WATER; XENOPUS LAEVIS;

EID: 0035889627     PISSN: 08873585     EISSN: None     Source Type: Journal    
DOI: 10.1002/prot.1136     Document Type: Article

References (38)

1. The MDM2 gene amplification database
2. Amplification and overexpression of the MDM2 gene in a subset of human malignant gliomas without p53 mutations
3. Amplification and overexpression of MDM in primary (de novo) glioblastomas
4. Amplification of a gene encoding a p53-associated protein in human sarcomas
5. p53: Functions, mutations and sarcomas
6. p53 and MDM2 alterations in osteosarcomas: Correlation with clinicopathologic features and proliferative rate
7. Low grade amplification of MDM2 gene in a subset of human breast cancers without p53 alterations
8. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation
9. Repression of p53-mediated transcription by MDM2: A dual mechanism
10. mdm2 promotes the rapid degradation of p53
11. Regulation of p53 stability by mdm2
12. mdm2 is a RING finger-dependent ubiquitin protein ligase for itself and p53
13. Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain
14. Discovery of potent antagonists of the interaction between human double minute 2 and tumor suppressor p53
15. A closer view of an oncoprotein-tumor suppressor interaction
16. Several hydrophobic amino acids in the p53 amino-terminal domain are required for transcriptional activation, binding to mdm-2 and the adenovirus 5 E1B 55-kD protein
17. The alpha-helical FXXPhiPhi motif in p53: TAF interaction and discrimination by MDM2
18. o/w more than the sum of its parts?
19. Hydropathic analysis of the non-covalent interactions between molecular subunits of structurally characterized hemoglobins
20. Computational methodology for estimating changes in free energies of biomolecular association upon mutation. The importance of bound water in dimer-tetramer assembly for beta 37 mutant hemoglobins
21. Allosteric modifiers of hemoglobin. 2. Crystallographically determined binding sites and hydrophobic binding/interaction analysis of novel hemoglobin oxygen effectors
22. New tools for modeling and understanding hydrophobicity and hydrophobic interactions
23. Differences in hydropathic properties of ligand binding at four independent sites in wheat germ agglutinin-oligosaccharide crystal complexes
24. Probing the binding of indolactam-V to protein kinase C through site-directed mutagenesis and computational docking simulations
25. Identification and hydropathic characterization of structural features affecting sequence specificity for doxorubicin intercalation into DNA double-stranded polynucleotides
26. Ligand docking and scoring in DNA oligonucleotide binding of doxorubicin and modeled analogs to optimize sequence specificity
27. A novel hydropathic intermolecular field analysis (HIFA) for the prediction of ligand-receptor binding affinities
28. All-atom models for the non-nucleoside binding site of HIV-1 reverse transcriptase complexed with inhibitors: A 3D QSAR approach
29. Structure-based design modifications of the paullone molecular scaffold for cyclin-dependent kinase inhibition
30. HINT: A new method of empirical hydrophobic field calculation for CoMFA
31. Three-dimensional quantitative structure-activity relationship study on cyclic urea derivatives as HIV-1 protease inhibitors: Application of comparative molecular field analysis
32. Molecular modeling of phenothiazines and related drugs as multidrug resistance modifiers: A comparative molecular field analysis study
33. Evaluating docked complexes with the HINT exponential function and empirical atomic hydrophobicities
34. Use of 3D QSAR methodology for data mining the National Cancer Institute repository of small molecules: Application to HIV-1 reverse transcriptase inhibition
35. Molecular characterization of the hdm2-p53 interaction
36. The protein data bank
37. Computational alanine scanning to probe protein-protein interactions: A novel approach to evaluate binding free energies